Building a leading one-stop ambulatory cancer center

February 2024 — SIAMH has successfully registered the offer document, launched an IPO and raised US$19.5 million.

SIAMH is a one-stop outpatient diagnostics and treatment center for cancer, neurogenerative and cardiovascular diseases in Singapore.

Our role in the transaction

Oaklins’ team in Singapore acted as sponsor, issue manager, underwriter and placement agent in this transaction.